Validation of a nomogram predicting the probability of lymph node invasion based on the extent of pelvic lymphadenectomy in patients with clinically localized prostate cancer

BJU International

Volumn 98, Issue 4, 2006, Pages 788-793

  Briganti, Alberto ^a,b   Chun, Felix K H ^b,c   Salonia, Andrea ^a   Gallina, Andrea ^a   Farina, Elena ^a   Da Pozzo, Luigi F ^a   Rigatti, Patrizio ^a   Montorsi, Francesco ^a   Karakiewicz, Pierre I ^b  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Lymph node invasion; Nomogram; Pelvic lymphadenectomy; Prostate cancer

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ACCURACY; ADULT; AGED; ARTICLE; CANCER INVASION; CANCER LOCALIZATION; CANCER STAGING; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; GLEASON SCORE; HUMAN; HUMAN TISSUE; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NOMOGRAM; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; PROBABILITY; PROSTATE CANCER; RADICAL RETROPUBIC PROSTATECTOMY; UNIVARIATE ANALYSIS; VALIDATION STUDY;

AGED; AGED, 80 AND OVER; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NOMOGRAMS; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 33748552691     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2006.06318.x     Document Type: Article

References (30)

1. Bader P, Burkhard FC, Markwalder R, Studer UE. Is a limited lymph node dissection an adequate staging procedure for prostate cancer? J Urol 2002; 168: 514-8
2. Heidenreich A, Varga Z, Von Knobloch R. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis. J Urol 2002; 167: 1681-6
3. Stone NN, Stock R, Unger P. Laparoscopic pelvic lymph node dissection for prostate cancer: comparison of the extended and modified technique. J Urol 1997; 158: 1891-4
4. Walsh PC, Partin AW, Epstein JI. Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years. J Urol 1994; 152: 1831-6
5. Gervasi LA, Mata J, Easley JD et al. Prognostic significance of lymph nodal metastases in prostate cancer. J Urol 1989; 142: 332-6
6. Catalona WJ, Smith DS. Cancer recurrence and survival rates after anatomic radical retropubic prostatectomy for prostate cancer: intermediate-term results. J Urol 1998; 160: 2428-34
7. Hull GW, Rabbani F, Abbas F, Wheeler TM, Kattan MW, Scardino PT. Cancer control with radical prostatectomy alone in 1,000 consecutive patients. J Urol 2002; 167: 528-34
8. Heicappell R, Muller-Mattheis V, Reinhardt M et al. Staging of pelvic lymph nodes in neoplasms of the bladder and prostate by positron emission tomography with 2-[(18)F]-2-deoxy-D-glucose. Eur Urol 1999; 36: 582-7
9. Engelbrecht MR, Barentsz JO, Jager GJ et al. Prostate cancer staging using imaging. BJU Int 2000; 86(Suppl. 1): 123-34
10. Rorvik J, Haukaas S. Magnetic resonance imaging of the prostate. Curr Opin Urol 2001; 11: 181-8
11. Lange PH. PROSTASCINT scan for staging prostate cancer. Urology 2001; 57: 402-6
12. Messing EM, Manola J, Sarosdy M, Wilding G, Crawford ED, Trump D. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with nodepositive prostate cancer. N Engl J Med 1999; 341: 1781-8
13. Bolla M, Gonzalez D, Warde P et al. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med 1997; 337: 295-300
14. Robnett TJ, Whittington R, Malkowicz SB et al. Long-term use of combined radiation therapy and hormonal therapy in the management of stage D1 prostate cancer. Int J Radiat Oncol Biol Phys 2002; 53: 1146-51
15. Gerstenbluth RE, Seftel AD, Hampel N, Oefelein MG, Resnick MI. The accuracy of the increased prostate specific antigen level (greater than or equal to 20 ng./ml.) in predicting prostate cancer: is biopsy always required? J Urol 2002; 168: 1990-3
16. Bochner BH, Herr HW, Reuter VE. Impact of separate versus en bloc pelvic lymph node dissection on the number of lymph nodes retrieved in cystectomy specimens. J Urol 2001; 166: 2295-6
17. Clark T, Parekh DJ, Cookson MS et al. Randomized prospective evaluation of extended versus limited lymph node dissection in patients with clinically localized prostate cancer. J Urol 2003; 169: 145-8
18. Cheng L, Zincke H, Blute ML, Bergstralh EJ, Scherer B, Bostwick DG. Risk of prostate carcinoma death in patients with lymph node metastasis. Cancer 2001; 91: 66-73
19. Palapattu GS, Allaf ME, Trock BJ, Epstein JI, Walsh PC. Prostate specific antigen progression in men with lymph node metastases following radical prostatectomy: results of long-term followup. J Urol 2004; 172: 1860-4
20. Bader P, Burkhard FC, Markwalder R, Studer UE. Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure? J Urol 2003; 169: 849-54
21. Bluestein DL, Bostwick DG, Bergstrahl EJ, Oesterling JE. Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer. J Urol 1994; 151: 1315-20
22. Bishoff JT, Reyes A, Thompson IM et al. Pelvic lymphadenectomy can be omitted in selected patients with carcinoma of the prostate: development of a system of patient selection. Urology 1995; 45: 270-4
23. Narayan P, Fournier G, Gajendran V et al. Utility of preoperative serum prostate-specific antigen concentration and biopsy Gleason score in predicting risk of pelvic lymph node metastases in prostate cancer. Urology 1994; 44: 519-24
24. Partin AW, Kattan MW, Subong EN et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA 1997; 277: 1445-51
25. Blute ML, Bergstralh EJ, Partin AW et al. Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer. J Urol 2000; 164: 1591-5
26. Penson DF, Grossfeld GD, Li YP, Henning JM, Lubeck DP, Carroll PR. How well does the Partin nomogram predict pathological stage after radical prostatectomy in a community based population? Results of the cancer of the prostate strategic urological research endeavor. J Urol 2002; 167: 1653-8
27. Cagiannos I, Karakiewicz P, Eastham JA et al. A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer. J Urol 2003; 170: 1798-803
28. Graefen M, Augustin H, Karakiewicz PI et al. Can predictive models for prostate cancer patients derived in the United States of America be utilized in European patients? A validation study of the Partin tables. Eur Urol 2003; 43: 6-11
29. Augustin H, Eggert T, Wenske S et al. Comparison of accuracy between the Partin tables of 1997 and 2001 to predict final pathological stage in clinically localized prostate cancer. J Urol 2004; 171: 177-81
30. Steuber T, Karakiewicz PI, Augustin H et al. Transition zone cancers undermine the predictive accuracy of Partin table stage predictors. J Urol 2005; 173: 737-41